With a greater number of patients seeking health information online and engaging in two-way conversations with other patients and caregivers via social media, the healthcare industry has entered an exciting and game-changing era.
In fact, 72 per cent of online U.S. adults have looked for health information online in the past year, and a similar proportion of European online consumers are social health users. Moreover, a recent study found that adoption of physician-only social networks by European doctors almost doubled in 2012.
It has never been more imperative for pharmaceutical companies to engage with their audiences and become part of the conversation – by building valuable relationships with patient communities, participating in disease awareness, listening and gaining insight into physician, patient, and community needs.
Weber Shandwick is widely known as a thought leader in digital media and communications trends in the healthcare industry. To answer the frequently asked question of how to build the social confidence of healthcare companies in a heavily regulated sector, Digital Health: Building Social Confidence in Pharma examines what social engagement means to a rapidly-changing pharmaceutical industry.
View Digital Health: Building Social Confidence in Pharma online or email ThoughtLeadership@webershandwick.com for more information about the publication
